NIH-funded research Sbir 2 grant

Using PhytoSERM to help manage menopausal hot flashes and support brain health.

Official title: PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health

Funded at Neutherapeutics, LLC · NIH-10707107 · Data updated 2026-11-12

This study is looking at how a new treatment called PhytoSERM can help relieve menopausal symptoms like hot flashes and support brain health in women going through menopause, offering a safer option than traditional hormone therapy.

More Hot Flashes research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionNeutherapeutics, LLC
NIH-funded
Lab location1 site (Tucson, United States)
Project startSeptember 30, 2022
Project endAugust 31, 2025
Funding year2023
Award (this year)$1,199,342
NIH project number5R44AG078102-02
Project IDNIH-10707107 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are symptomatic peri- and post-menopausal women experiencing hot flashes and at risk for Alzheimer's disease.

Less likely to help

Patients who are not experiencing menopausal symptoms or who are not female may not benefit from this research.

What this research studies

This research investigates the effects of PhytoSERM, a selective estrogen receptor beta modulator, on menopausal symptoms and brain health in women. The study aims to provide an alternative to traditional hormone therapy, which many women avoid due to concerns about breast cancer. By targeting estrogen action specifically in the brain while minimizing effects in breast tissue, PhytoSERM could help alleviate hot flashes and potentially reduce the risk of Alzheimer's disease. The research involves a Phase 2 clinical trial with a randomized, placebo-controlled design to assess the efficacy and safety of PhytoSERM in peri- and post-menopausal women.

Why it matters

Potential benefit: If successful, this research could provide a safer treatment option for menopausal symptoms while also supporting cognitive health in women.

How similar studies have gone: Previous studies have shown promising results with similar approaches, indicating potential for success in this area.

Where this research is happening

  • Neutherapeutics, LLC
    Tucson, United States
    Active

Researchers

  • Principal investigator: Rinehart, John — Neutherapeutics, LLC
  • Study coordinator: Rinehart, John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.